ADMA Biologics, Inc. (ADMA)
9.11
+0.16
(+1.79%)
USD |
NASDAQ |
Sep 18, 16:00
9.125
+0.02
(+0.16%)
After-Hours: 20:00
ADMA Biologics 30-Day Average Daily Volume : 2.404M for Sept. 18, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 18, 2026 | 2.404M |
| September 17, 2026 | 2.211M |
| September 16, 2026 | 2.267M |
| September 15, 2026 | 2.268M |
| September 14, 2026 | 2.235M |
| September 11, 2026 | 2.186M |
| September 10, 2026 | 2.154M |
| September 09, 2026 | 2.133M |
| September 08, 2026 | 2.126M |
| September 04, 2026 | 2.139M |
| September 03, 2026 | 2.170M |
| September 02, 2026 | 2.213M |
| September 01, 2026 | 2.213M |
| August 31, 2026 | 2.240M |
| August 28, 2026 | 2.265M |
| August 27, 2026 | 2.390M |
| August 26, 2026 | 2.433M |
| August 25, 2026 | 2.459M |
| August 24, 2026 | 2.500M |
| August 21, 2026 | 2.530M |
| August 20, 2026 | 2.559M |
| August 19, 2026 | 2.553M |
| August 18, 2026 | 2.539M |
| August 17, 2026 | 2.571M |
| August 14, 2026 | 2.609M |
| Date | Value |
|---|---|
| August 13, 2026 | 2.711M |
| August 12, 2026 | 2.709M |
| August 11, 2026 | 2.737M |
| August 10, 2026 | 2.796M |
| August 07, 2026 | 2.931M |
| August 06, 2026 | 2.940M |
| August 05, 2026 | 2.859M |
| August 04, 2026 | 2.832M |
| August 03, 2026 | 2.862M |
| July 31, 2026 | 3.073M |
| July 30, 2026 | 3.127M |
| July 29, 2026 | 3.197M |
| July 28, 2026 | 3.274M |
| July 27, 2026 | 3.303M |
| July 24, 2026 | 3.372M |
| July 23, 2026 | 3.433M |
| July 22, 2026 | 3.450M |
| July 21, 2026 | 3.474M |
| July 20, 2026 | 3.472M |
| July 17, 2026 | 3.462M |
| July 16, 2026 | 3.373M |
| July 15, 2026 | 3.389M |
| July 14, 2026 | 3.436M |
| July 13, 2026 | 3.449M |
| July 10, 2026 | 3.446M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Erasca, Inc. | 4.052M |
| Vericel Corp. | 501433.5 |
| BioMarin Pharmaceutical, Inc. | 2.190M |
| Emergent BioSolutions, Inc. | 1.426M |
| Exelixis, Inc. | 2.278M |